Too Many New Mothers Silent on Postpartum Depression

Share this content:
Too Many New Mothers Silent on Postpartum Depression
Too Many New Mothers Silent on Postpartum Depression

WEDNESDAY, Aug. 30, 2017 (HealthDay News) -- One in five new mothers who develops postpartum depression or another mood disorder after childbirth suffer in silence, according to a study published online Aug. 1 in the Maternal and Child Health Journal.

Betty-Shannon Prevatt, a clinical psychologist and Ph.D. student at North Carolina State University in Raleigh, and colleagues asked 211 women who had given birth within the past three years to participate in an anonymous survey. The mothers were asked if they had any symptoms of postpartum mood disorders and if they told a doctor, nurse, lactation consultant, or doula about these symptoms. They were also asked about any barriers that would prevent them from seeking care.

The survey showed that 51 percent of the mothers involved in the study met criteria for a postpartum mood disorder. Of that group, about 20 percent never told a health care provider about their struggles. New mothers who had the highest stress levels and those with the strongest support networks were more likely to seek out help for a mood disorder after childbirth, the researchers noted. Overall, women who were unemployed, had a history of mental health issues, or had the most severe symptoms of a mood disorder were more likely to report various problems accessing needed care.

"This work highlights the importance of support networks and the need to normalize the wide variety of reactions women have after childbirth," Prevatt said in a university news release. "We need to make it okay for women to talk about their mental health, so that they can have better access to care. Working with the people around new mothers may be key."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »